Known hypersensitivity to any oligodeoxynucleotide.
Known hypersensitivity to any of the study drugs
Known hypersensitivity to thalidomide.
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs or analogs
Patients with known prior hypersensitivity reaction to any of the study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to study drugs;
Known hypersensitivity to one or more of the study agents
Known hypersensitivity to any of the study drugs or analogs
Known hypersensitivity to the study drugs or the drugs with similar chemical structures
Known hypersensitivity to one or more of the study agents
Known hypersensitivity to the trial drugs (volasertib and romidepsin)
Known hypersensitivity to any of the study drugs
Known hypersensitivity to one or more of the study agents
Known hypersensitivity to thalidomide
Prior use of gossypol or AT-101, or known hypersensitivity to gossypol or AT-101
Known hypersensitivity to thalidomide
Patients with a known hypersensitivity to any of the study agents
Known hypersensitivity to thalidomide.
Known allergy or hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study agents
Known hypersensitivity to thalidomide
Known hypersensitivity to thalidomide or rituximab
Known hypersensitivity to one or more of the study agents
Patients with known hypersensitivity to any oligodeoxynucleotide.
Known hypersensitivity to any of the study drugs
Known hypersensitivity to thalidomide
Known hypersensitivity to any of the study drugs
Known anaphylactic or severe hypersensitivity to the study drugs or their analogs
Known hypersensitivity to thalidomide
Known anaphylactic or severe hypersensitivity to study drugs or their analogs
Known hypersensitivity to thalidomide
Known hypersensitivity to thalidomide.
Known hypersensitivity to any of the study agents
Any contraindication or known allergy or hypersensitivity to any study drugs
Patient has known hypersensitivity to thalidomide
Known hypersensitivity to thalidomide
Known hypersensitivity to thalidomide
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs involved
Known hypersensitivity to thalidomide or other immunomodulatory drugs.
Known hypersensitivity to thalidomide
Known hypersensitivity to the study drugs
Known hypersensitivity to the study drugs
Known hypersensitivity to polymyxin B
Known hypersensitivity to any of the study drugs
Have known hypersensitivity to pancuronium bromide, atracurium or cisatracurium,
Any known hypersensitivity to dexmedetomidine
Known hypersensitivity to one or more of the study agents
